Pharmaceuticals 2013, 6(7), 837-850; doi:10.3390/ph6070837

Diamidines versus Monoamidines as Anti-Pneumocystis Agents: An in Vivo Study

1 Laboratory of Organic Chemistry, University of Mons-UMONS, B-7000 Mons, Belgium 2 Biology & Diversity of Emerging Eukaryotic Pathogens (BDEEP), Center for Infection and Immunity of Lille (CIIL), INSERM U1019, CNRS UMR 8204, EA-4547, Univ Lille Nord de France, UDSL, Institut Pasteur de Lille, F-59000 Lille, France 3 EA2694, Department of Biostatistics, Université de Lille Nord de France, F-59000 Lille, France 4 Department of General, Organic, and Biomedical Chemistry, NMR and Molecular Imaging Laboratory, University of Mons-UMONS, B-7000 Mons, Belgium 5 CHU Lille, Biology & Pathology Center, Parasitology-Mycology, F-59000 Lille, France
* Author to whom correspondence should be addressed.
Received: 22 April 2013; in revised form: 14 May 2013 / Accepted: 17 June 2013 / Published: 1 July 2013
(This article belongs to the Special Issue Antimicrobial Agents)
PDF Full-text Download PDF Full-Text [428 KB, Updated Version, uploaded 3 July 2013 15:17 CEST]
The original version is still available [491 KB, uploaded 1 July 2013 14:53 CEST]
Abstract: Some compounds articulated around a piperazine or an ethylenediamine linker have been evaluated in vitro to determine their activity in the presence of a 3T6 fibroblast cell line and an axenic culture of Pneumocystis carinii, respectively. The most efficient antifungal derivatives, namely N,N′-bis(benzamidine-4-yl)ethane-1,2-diamine (compound 6, a diamidine) and N-(benzamidine-4-yl)-N′-phenylethane-1,2-diamine (compound 7, a monoamidine), exhibited no cytotoxicity and were evaluated in vivo in a rat model. Only the diamidine 6 emerged as a promising hit for further studies.
Keywords: Pneumocystis; pentamidine; diamidine

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Stanicki, D.; Pottier, M.; Gantois, N.; Pinçon, C.; Forge, D.; Mahieu, I.; Boutry, S.; Eynde, J.J.V.; Martinez, A.; Dei-Cas, E.; Aliouat, E.-M. Diamidines versus Monoamidines as Anti-Pneumocystis Agents: An in Vivo Study. Pharmaceuticals 2013, 6, 837-850.

AMA Style

Stanicki D, Pottier M, Gantois N, Pinçon C, Forge D, Mahieu I, Boutry S, Eynde JJV, Martinez A, Dei-Cas E, Aliouat E-M. Diamidines versus Monoamidines as Anti-Pneumocystis Agents: An in Vivo Study. Pharmaceuticals. 2013; 6(7):837-850.

Chicago/Turabian Style

Stanicki, Dimitri; Pottier, Muriel; Gantois, Nausicaa; Pinçon, Claire; Forge, Delphine; Mahieu, Isabelle; Boutry, Sébastien; Eynde, Jean J.V.; Martinez, Anna; Dei-Cas, Eduardo; Aliouat, El-Moukhtar. 2013. "Diamidines versus Monoamidines as Anti-Pneumocystis Agents: An in Vivo Study." Pharmaceuticals 6, no. 7: 837-850.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert